急性至亚急性期孤立性颅内动脉粥样硬化性血栓性卒中相关大血管闭塞的最佳血管内治疗技术
本研究为51中心历史性多中心注册研究,纳入770例、分析509例孤立性颅内动脉粥样硬化性血栓性卒中相关大血管闭塞患者,按血管内治疗技术分为单纯机械取栓组、经皮腔内血管成形术(PTA)组和支架置入组。结果显示PTA组再闭塞率显著低于单纯机械取栓组(校正风险比0.48,95%CI 0.29-0.80),支架置入组与单纯机械取栓组再闭塞率无显著差异,83.5%的再闭塞发生在血管内治疗后10天内、约62.0%发生在2天内,3组90天mRS 0-2分比例及症状性颅内出血、其他颅内出血和死亡发生率均无显著差异。
要点
- PTA组再闭塞率显著低于单纯机械取栓组,校正风险比0.48(95%CI 0.29-0.80)。
- 支架置入组与单纯机械取栓组再闭塞率无显著差异。
- 83.5%的再闭塞发生在血管内治疗后10天内,约62.0%发生在2天内。
核心结论
- PTA组再闭塞发生率显著低于单纯机械取栓组,支架置入组与单纯机械取栓组再闭塞率无有意义差异;再闭塞多发生在血管内治疗后10天内、尤其2天内。
研究设计与样本
- 历史性多中心注册研究,51个中心,纳入770例、分析509例孤立性颅内动脉粥样硬化性血栓性卒中相关大血管闭塞患者,按血管内治疗技术分为单纯机械取栓组、PTA组和支架置入组,主要结局为血管内治疗完成后90天内治疗血管再闭塞发生率。
关键影像表现/征象
- 单纯机械取栓组、PTA组和支架置入组的再闭塞率分别为40.7%、44.4%和14.9%。
- 最终造影残余狭窄>70%的发生率单纯机械取栓组 vs PTA组 vs 支架置入组为34.5% vs 26.3% vs 13.2%,P=0.002。
- 83.5%的患者再闭塞发生在血管内治疗后10天内,约62.0%的患者在血管内治疗后2天内发生再闭塞。
诊断标准与关键数值
- 再闭塞率:单纯机械取栓组40.7% vs PTA组44.4% vs 支架置入组14.9%。
- PTA组 vs 单纯机械取栓组再闭塞校正风险比0.48(95%CI 0.29-0.80)。
- 最终造影残余狭窄>70%发生率:单纯机械取栓组34.5% vs PTA组26.3% vs 支架置入组13.2%,P=0.002。
- 90天mRS 0-2分比例、症状性颅内出血、其他颅内出血和死亡发生率3组间无显著差异。
临床应用与阅片要点
- 原文指出在日本糖蛋白IIb/IIIa抑制剂不在医保报销范围内,因此鉴于单纯机械取栓再闭塞风险较高,PTA可能是AT-LVO的首选选择。
- 再闭塞很可能发生在血管内治疗后10天内,尤其是治疗后2天内。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Reocclusion after treatment is a concern in endovascular therapy for isolated intracranial atherothrombotic stroke-related large-vessel occlusion (AT-LVO). However, the optimal endovascular therapy technique for AT-LVO has not yet been investigated. This study evaluated the optimal endovascular therapy technique for AT-LVO in a real-world setting.
MATERIALS AND METHODS: We conducted a historical, multicenter registry study at 51 centers that enrolled patients with AT-LVO. We divided the patients into 3 groups based on the endovascular therapy technique: mechanical thrombectomy alone, percutaneous transluminal angioplasty (PTA), and stent deployment. Mechanical thrombectomy alone was classified into the mechanical thrombectomy-only group; PTA and mechanical thrombectomy-PTA, into the PTA group; and mechanical thrombectomy-stent deployment, mechanical thrombectomy-PTA-stent deployment, PTA-stent deployment, and stent deployment-only into the stent group. The primary outcome was incidence of reocclusion of the treated vessels within 90 days of endovascular therapy completion.
RESULTS: We enrolled 770 patients and analyzed 509 patients. The rates in the mechanical thrombectomy-only, PTA, and stent deployment groups were 40.7%, 44.4%, and 14.9%, respectively. Incidence rate of residual stenosis >70% of final angiography was significantly higher in the mechanical thrombectomy-only group than in the PTA and stent deployment groups (mechanical thrombectomy-only versus PTA versus stent deployment: 34.5% versus 26.3% versus 13.2%, P = .002). Reocclusion rate was significantly lower in the PTA group than in the mechanical thrombectomy-only group (adjusted hazard ratio, 0.48; 95% CI, 0.29-0.80). Of the patients, 83.5% experienced reocclusion within 10 days after endovascular therapy. Alarmingly, a substantial subset (approximately 62.0%) of patients experienced reocclusion within 2 days of endovascular therapy. Incidence of mRS scores of 0-2 ninety days after endovascular therapy was not significantly different among the 3 groups. Incidences of symptomatic intracranial hemorrhage, any other intracranial hemorrhage, and death were not significantly different.
CONCLUSIONS: Incidence rate of reocclusion was significantly lower in the PTA group than in the mechanical thrombectomy-only group. We found no meaningful difference in reocclusion rates between the stent deployment and mechanical thrombectomy-only groups. In Japan, glycoprotein IIb/IIIa inhibitors are not reimbursed. Therefore, PTA might be the preferred choice for AT-LVOs due to the higher reocclusion risk with mechanical thrombectomy-only. Reocclusion was likely to occur within 10 days, particularly within 2 days post-endovascular therapy.
引用
- Beppu M, Uchida K, Sakai N, et al. Optimal Endovascular Therapy Technique for Isolated Intracranial Atherothrombotic Stroke-Related Large-Vessel Occlusion in the Acute-to-Subacute Stage. AJNR Am J Neuroradiol. 2024. PMID: 38951032. doi:10.3174/ajnr.A8399
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。